Stock Details
SYK is Stryker Corporation's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 213.07$. Average daily volumn in 3 months 1.48M. Market cap 78.29B



Stock symbol : SYK. Exchange : NYSE. Currency : USD
Lastest price : 206.93$. Total volume : 1.33M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Stryker Corporation (SYK)
Last Price
206.93$
Change
-1.95
Volume
1.33M

Previous Close208.88
Open207.42
Day Range202.60-207.99
Bid200.85 x 1.1k
Ask213.19 x 1k
Volume1.33M
Average Volume1.48M
Market Cap78.29B
Beta1.03
52 Week Range188.84-280.43
Trailing P/E38.11
Foward P/E20.03
Dividend (Yield %)1.33%
Ex-Dividend Date2022-09-29



Financial Details


According to Stryker Corporation's financial reports the company's revenue in 2021 were 17.11B an increase( +21.43%) over the years 2020 revenue that were of 14.35B. In 2021 the company's total earnings were 1.99B while total earnings in 2020 were 1.6B(0%).


Loading ...



Organization

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotech... nology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Market Cap:
78.29B
Revenue:
17.11B
Total Assets:
34.63B
Total Cash:
2.94B


News about "Stryker Corporation"

stryker-co-nysesyk-position-increased-by-allworth-financial-lp-image

Stryker Co. (NYSE:SYK) Position Increased by Allworth Financial LP

Source from : Defense World - 13 hours ago

Allworth Financial LP raised its holdings in shares of Stryker Co. (NYSE:SYK – Get Rating) by 143.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and ...See details»


acg-wealth-buys-shares-of-304-stryker-co-nysesyk-image

ACG Wealth Buys Shares of 304 Stryker Co. (NYSE:SYK)

Source from : Defense World - 11 hours ago

ACG Wealth bought a new stake in Stryker Co. (NYSE:SYK – Get Rating) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund ...See details»


heres-why-you-should-retain-stryker-syk-stock-for-now-image

Here's Why You Should Retain Stryker (SYK) Stock For Now

Source from : YAHOO!Finance - 3 days ago

Stryker (SYK) continues to benefit from strength in the robotic-arm assisted surgery platform, Mako, and broad product portfolio. However, pricing pressure weighs on it.See details»


Stryker's (SYK) OptaBlate Tumor Ablation System Gets FDA Nod

Source from : Nasdaq - 1 days ago

OptaBlate is the first FDA-approved system with microinfusion technology anticipated to be a reliable solution for painful metastatic tumors in cancer patients. The approval for OptaBlate boosts ...See details»


the-zacks-analyst-blog-highlights-microsoft-danaher-raytheon-technologies-stryker-corporation-and-vale-image

The Zacks Analyst Blog Highlights Microsoft, Danaher, Raytheon Technologies, Stryker Corporation and Vale

Source from : YAHOO!Finance - 2 days ago

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corp., Danaher Corp. and ...See details»


Stryker Gets FDA 510(k) Clearance For OptaBlate Bone Tumor Ablation System

Source from : Nasdaq - 4 days ago

(RTTNews) - Medical technology company Stryker Corp. (SYK) announced Tuesday that its OptaBlate bone tumor ablation system (OptaBlate) received 510(k) clearance from the U.S. Food and Drug ...See details»


Stryker Corporation's (NYSE:SYK) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Source from : Yahoo Finance - 6 days ago

Stryker (NYSE:SYK) has had a great run on the share market with its stock up by a significant 14% over the last three months. Given that stock prices are usually aligned with a company's financial ...See details»


Should You Buy Stryker Stock Around $225?

Source from : Forbes - 8 days ago

Stryker stock (NYSE: SYK), a medical devices company, has seen a 15% fall this year, in line with the broader S&P500 index, down 17%. Even if we look at the longer term, SYK stock, with 46% ...See details»


temperature-management-market-to-reach-us-38143-million-at-a-cagr-of-42-by-2028-3m-zoll-medical-corporation-stryker-corporation-image

Temperature Management Market to Reach US$ 3,814.3 Million at a CAGR of 4.2% By 2028 | 3M, Zoll Medical Corporation, Stryker Corporation

Source from : Medgadget - 1 days ago

Request Here For The Sample Copy Of The Report @ The worldwide temperature management market had a value of US$ 2,856.6 million in 2021 and is anticipated to grow at a CAGR of 4.2% from 2022 to 2028 ...See details»


fda-clears-stryker-bone-tumor-ablation-system-image

FDA clears Stryker bone tumor ablation system

Source from : MassDevice - 4 days ago

Stryker (NYSE:SYK) announced today that the FDA granted 510(k) clearance for its OptaBlate bone tumor ablation system.See details»


stryker-launches-delivery-system-for-foot-ankle-procedures-image

Stryker launches delivery system for foot, ankle procedures

Source from : MassDevice - 10 days ago

Stryker (NYSE:SYK) announced today that it launched its Pulse intelligent delivery platform for high-volume foot and ankle procedures.See details»


Smart Beds Market Insights, Rising Trends and Global Demand 2022- Stryker Corporation, ArjoHuntleigh AB, Hill Rom Holdings, Paramount Bed, LINET spol

Source from : Digital Journal - 9 days ago

Key players which are covered in the global Smart Beds market are Stryker Corporation, ArjoHuntleigh AB, Hill Rom Holdings, Paramount Bed, LINET spol, Invacare Corporation, Select Comfort ...See details»


Lumbar Disc Replacement Device Market Is Booming At A CAGR Of 13.5% By 2028 | Axiomed, Stryker Corp

Source from : MENAFN - 12 days ago

Lumbar DiscReplacement Device Market SEATTLE, UNITED STATES, UNITED STATES, September 12, 2022 /EINPresswire.com / -- Coherent Market Ins ...See details»


Surgical Robotics Market Recovery and Impact Analysis Report Renishaw plc, Stryker Corporation, Intuitive Surgical Inc.

Source from : Digital Journal - 9 days ago

New Jersey, United States, Sept. 15, 2022 /DigitalJournal/ Robotic surgery are types of surgical procedures that are performed using robotic systems. Robot-assisted surgery was developed in an ...See details»